Mahshid Arfania Assadi, MD Internal Medicine - Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 25 Central Park West, Suite 1m Mahshid Arfania Assadi Md Pc, Nyc, NY 10023 Phone: 212-315-3322 Fax: 212-307-0734 |
News Archive
NIBIB-funded researchers at the Massachusetts General Hospital have developed a smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.
Medivir AB, is an expanding, research-based specialty pharmaceutical company focusing on infectious diseases. Medivir reports that on 25 August, BioPhausia AB reached an agreement to sell its generics business in the form of subsidiary BMM Pharma AB to Bluefish Pharmaceuticals AB for SEK 26 m plus the value of inventories, some SEK 12 m.
Bio-compatible electrostrictive materials will play a leading role in the future generation of medical micro-electro-mechanical systems (MEMS).
A rapid Zika test, developed by an international, multi-institutional team of researchers led by synthetic biologist James Collins, Ph.D., at Harvard University's Wyss Institute for Biologically Inspired Engineering, has today been named a 2016 "Best of What's New" awards winner by Popular Science magazine in the Health category.
Touro Infirmary implemented Centricity Perinatal in the NICU in December 2010, completing its roll out to all perinatal units, with the goal of providing the most up-to-date and innovative care available. The site chose the scalable system as a key to further customization and to enhance the ability to implement changes quickly as patient care situations evolve.
› Verified 3 days ago